John Parks to Hypercholesterolemia
This is a "connection" page, showing publications John Parks has written about Hypercholesterolemia.
Connection Strength
0.189
-
Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, Eckel RH, Schaefer EJ, Lichtenstein AH. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004 Jun; 24(6):1092-7.
Score: 0.058
-
Malloy SI, Altenburg MK, Knouff C, Lanningham-Foster L, Parks JS, Maeda N. Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3. Arterioscler Thromb Vasc Biol. 2004 Jan; 24(1):91-7.
Score: 0.056
-
Parks JS, Lehner ND, St Clair RW, Lofland HB. Whole-body cholesterol metabolism in cholesterol-fed African green monkeys with a variable hypercholesterolemic response. J Lab Clin Med. 1977 Dec; 90(6):1021-34.
Score: 0.038
-
Cao Q, Cui X, Wu R, Zha L, Wang X, Parks JS, Yu L, Shi H, Xue B. Myeloid Deletion of a1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice. Diabetes. 2016 06; 65(6):1565-76.
Score: 0.033
-
Rudel LL, Parks JS, Johnson FL, Babiak J. Low density lipoproteins in atherosclerosis. J Lipid Res. 1986 May; 27(5):465-74.
Score: 0.004